UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 68 filers reported holding UROGEN PHARMA LTD in Q1 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44 | -87.6% | 3,150 | -90.8% | 0.00% | – |
| Q2 2023 | $355 | +9.9% | 34,339 | -1.8% | 0.00% | – |
| Q1 2023 | $323 | +1013.8% | 34,961 | +959.4% | 0.00% | – |
| Q4 2022 | $29 | -99.9% | 3,300 | -14.2% | 0.00% | – |
| Q3 2022 | $31,000 | – | 3,845 | +3104.2% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 120 | -58.0% | 0.00% | – |
| Q1 2022 | $2,000 | +100.0% | 286 | +43.7% | 0.00% | – |
| Q4 2021 | $1,000 | – | 199 | +2111.1% | 0.00% | – |
| Q3 2021 | $0 | – | 9 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 9 | -97.5% | 0.00% | – |
| Q1 2021 | $7,000 | +40.0% | 361 | +26.2% | 0.00% | – |
| Q4 2020 | $5,000 | -98.8% | 286 | -97.7% | 0.00% | -100.0% |
| Q4 2019 | $409,000 | +154.0% | 12,262 | +81.4% | 0.00% | – |
| Q3 2019 | $161,000 | – | 6,758 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,620,545 | $36,713,835 | 6.69% |
| Wildcat Capital Management, LLC | 495,606 | $6,943,440 | 2.79% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 508,883 | $7,129,451 | 2.16% |
| Opaleye Management Inc. | 320,000 | $4,483,200 | 1.46% |
| AlphaCentric Advisors LLC | 165,000 | $2,311,650 | 1.31% |
| Soleus Capital Management, L.P. | 372,000 | $5,211,720 | 0.48% |
| EAM Investors, LLC | 170,523 | $2,389,027 | 0.46% |
| RA Capital Management | 1,483,697 | $20,786,595 | 0.41% |
| Parkman Healthcare Partners LLC | 145,311 | $2,035,807 | 0.37% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,303,031 | $32,265,464 | 0.29% |